← Back to federal legislation
S. 483In committee

Responsibility in Drug Advertising Act of 2025

Introduced: Feb 6, 2025

Latest action date: Feb 6, 2025

Latest development

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Congress
119th Congress
Introduced
Feb 6, 2025
Recorded roll calls
0

Status detail: The most advanced recorded stage is committee consideration.

Plain-language overview

What this bill does

Responsibility in Drug Advertising Act of 2025

This bill prohibits direct-to-consumer advertising of new drugs during the first three years following their approval by the Food and Drug Administration (FDA). Direct-to-consumer advertising includes advertising via social media. 

Upon request from a drug’s sponsor, the FDA may waive the prohibition during the third year following a drug’s approval if it determines that the direct-to-consumer advertising of the drug would have an affirmative value to public health. Conversely, the FDA may prohibit such advertising beyond the three-year period following approval if it determines that the drug has significant adverse health effects based on post-approval studies, adverse event reports, and other appropriate resources. 

The prohibition applies to new drugs approved beginning one year before the bill’s enactment.

Official summary from Congress.gov.

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

View 5 official legislative subjects
Broadcasting, cable, digital technologiesDrug safety, medical device, and laboratory regulationInternet, web applications, social mediaMarketing and advertisingPrescription drugs

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Oct 17, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline2 actions
  1. Introduced in Senate

    IntroReferralLibrary of Congress
  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    IntroReferralSenate

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Sources: Congress.gov and official House and Senate vote records.

View data freshness details

Base metadata check pending · Civixly summary check pending · Action timeline checked Oct 17, 2026 · Complete sponsorship check pending · Topics checked Oct 17, 2026 · Committees checked Oct 17, 2026 · Status checked Oct 17, 2026 · Related bills checked Oct 17, 2026.